These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28382874)

  • 21. Visual working memory deterioration preceding relapse in psychosis.
    Hui CL; Li YK; Li AW; Lee EH; Chang WC; Chan SK; Lam SY; Thornton AE; Sham P; Honer WG; Chen EY
    Psychol Med; 2016 Aug; 46(11):2435-44. PubMed ID: 27305830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adolescent vs. adult onset of a first episode psychosis: Impact on remission of positive and negative symptoms.
    Veru F; Jordan G; Joober R; Malla A; Iyer S
    Schizophr Res; 2016 Jul; 174(1-3):183-188. PubMed ID: 27102425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement in verbal learning over the first year of antipsychotic treatment is associated with serum HDL levels in a cohort of first episode psychosis patients.
    Gjerde PB; Simonsen CE; Lagerberg TV; Steen NE; Ueland T; Andreassen OA; Steen VM; Melle I
    Eur Arch Psychiatry Clin Neurosci; 2020 Feb; 270(1):49-58. PubMed ID: 31028479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Risperidone in the early treatment of first-episode psychosis: a two-year follow-up study].
    Gutiérrez Fraile M; Segarra Echevarría R; González-Pinto Arrillaga A; Martínez Junquera G
    Actas Esp Psiquiatr; 2002; 30(3):142-52. PubMed ID: 12106515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective relationship between duration of untreated psychosis and 13-year clinical outcome: a first-episode psychosis study.
    Tang JY; Chang WC; Hui CL; Wong GH; Chan SK; Lee EH; Yeung WS; Wong CK; Tang WN; Chan WF; Pang EP; Tso S; Ng RM; Hung SF; Dunn EL; Sham PC; Chen EY
    Schizophr Res; 2014 Mar; 153(1-3):1-8. PubMed ID: 24529612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic review.
    Zipursky RB; Menezes NM; Streiner DL
    Schizophr Res; 2014 Feb; 152(2-3):408-14. PubMed ID: 23972821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can antipsychotic dose reduction lead to better functional recovery in first-episode psychosis? A randomized controlled-trial of antipsychotic dose reduction. The reduce trial: Study protocol.
    Weller A; Gleeson J; Alvarez-Jimenez M; McGorry P; Nelson B; Allott K; Bendall S; Bartholomeusz C; Koval P; Harrigan S; O'Donoghue B; Fornito A; Pantelis C; Paul Amminger G; Ratheesh A; Polari A; Wood SJ; van der El K; Ellinghaus C; Gates J; O'Connell J; Mueller M; Wunderink L; Killackey E
    Early Interv Psychiatry; 2019 Dec; 13(6):1345-1356. PubMed ID: 30488637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Should Antipsychotic Medications for Schizophrenia Be Given for a Lifetime?: A Naturalistic, Long-Term Follow-Up Study.
    Glick ID; Davis JM; Zamora D; Ballon J; Nuthi M
    J Clin Psychopharmacol; 2017 Apr; 37(2):125-130. PubMed ID: 28195931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Five-fold increased risk of relapse following breaks in antipsychotic treatment of first episode psychosis.
    Winton-Brown TT; Elanjithara T; Power P; Coentre R; Blanco-Polaina P; McGuire P
    Schizophr Res; 2017 Jan; 179():50-56. PubMed ID: 27745754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting 1-year risk for relapse in patients who have discontinued or continued quetiapine after remission from first-episode psychosis.
    Hui CL; Wong GH; Tang JY; Chang WC; Chan SK; Lee EH; Lam MM; Chiu CP; Law CW; Chung DW; Tso S; Pang EP; Chan KT; Wong YC; Mo FY; Chan KP; Hung SF; Honer WG; Chen EY
    Schizophr Res; 2013 Oct; 150(1):297-302. PubMed ID: 23993865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach.
    Castro-Fornieles J; Parellada M; Soutullo CA; Baeza I; Gonzalez-Pinto A; Graell M; Paya B; Moreno D; de la Serna E; Arango C
    J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):327-36. PubMed ID: 18759642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era.
    Alvarez-Jimenez M; O'Donoghue B; Thompson A; Gleeson JF; Bendall S; Gonzalez-Blanch C; Killackey E; Wunderink L; McGorry PD
    CNS Drugs; 2016 May; 30(5):357-68. PubMed ID: 27106296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors.
    Demjaha A; Lappin JM; Stahl D; Patel MX; MacCabe JH; Howes OD; Heslin M; Reininghaus UA; Donoghue K; Lomas B; Charalambides M; Onyejiaka A; Fearon P; Jones P; Doody G; Morgan C; Dazzan P; Murray RM
    Psychol Med; 2017 Aug; 47(11):1981-1989. PubMed ID: 28395674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and demographic predictors of continuing remission or relapse following discontinuation of antipsychotic medication after a first episode of psychosis. A systematic review.
    Bowtell M; Ratheesh A; McGorry P; Killackey E; O'Donoghue B
    Schizophr Res; 2018 Jul; 197():9-18. PubMed ID: 29146020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting relapse after a first episode of non-affective psychosis: a three-year follow-up study.
    Caseiro O; Pérez-Iglesias R; Mata I; Martínez-Garcia O; Pelayo-Terán JM; Tabares-Seisdedos R; Ortiz-García de la Foz V; Vázquez-Barquero JL; Crespo-Facorro B
    J Psychiatr Res; 2012 Aug; 46(8):1099-105. PubMed ID: 22721546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychotic Symptoms and Attitudes toward Medication Mediate the Effect of Insight on Personal-Social Functions in Patients with Schizophrenia: One-Year Randomized Controlled Trial and Follow-Up.
    Zheng Y; Ning Y; She S; Deng Y; Chen Y; Yi W; Lu X; Chen X; Li J; Li R; Zhang J; Xiao D; Wu H; Wu C
    Psychopathology; 2018; 51(3):167-176. PubMed ID: 29444522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment and violent behavior in persons with first episode psychosis during a 10-year prospective follow-up study.
    Langeveld J; Bjørkly S; Auestad B; Barder H; Evensen J; Ten Velden Hegelstad W; Joa I; Johannessen JO; Larsen TK; Melle I; Opjordsmoen S; Røssberg JI; Rund BR; Simonsen E; Vaglum P; McGlashan T; Friis S
    Schizophr Res; 2014 Jul; 156(2-3):272-6. PubMed ID: 24837683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
    Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
    Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effect of Substance Use on 10-Year Outcome in First-Episode Psychosis.
    Weibell MA; Hegelstad WTV; Auestad B; Bramness J; Evensen J; Haahr U; Joa I; Johannessen JO; Larsen TK; Melle I; Opjordsmoen S; Rund BR; Simonsen E; Vaglum P; McGlashan T; McGorry P; Friis S
    Schizophr Bull; 2017 Jul; 43(4):843-851. PubMed ID: 28199703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.